Cargando…

A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation

The scarcity of age-appropriate pharmaceutical formulations is one of the major challenges impeding successful management of tuberculosis (TB) prevalence in minors. To this end, we designed and assessed the quality of a multiparticulate reconstitutable suspension powder containing fixed dose rifampi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rampedi, Penelope N., Ogunrombi, Modupe O., Wesley-Smith, James, Adeleke, Oluwatoyin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861895/
https://www.ncbi.nlm.nih.gov/pubmed/36678693
http://dx.doi.org/10.3390/pharmaceutics15010064
_version_ 1784874956144771072
author Rampedi, Penelope N.
Ogunrombi, Modupe O.
Wesley-Smith, James
Adeleke, Oluwatoyin A.
author_facet Rampedi, Penelope N.
Ogunrombi, Modupe O.
Wesley-Smith, James
Adeleke, Oluwatoyin A.
author_sort Rampedi, Penelope N.
collection PubMed
description The scarcity of age-appropriate pharmaceutical formulations is one of the major challenges impeding successful management of tuberculosis (TB) prevalence in minors. To this end, we designed and assessed the quality of a multiparticulate reconstitutable suspension powder containing fixed dose rifampicin and pyrazinamide (150 mg/300 mg per 5 mL) which was prepared employing solid–liquid direct dispersion coupled with timed dehydration, and mechanical pulverization. The optimized formulation had a high production yield (96.000 ± 3.270%), displayed noteworthy powder flow quality (9.670 ± 1.150°), upon reconstitution the suspension flow property was non-Newtonian and was easily redispersible with gentle manual agitation (1.720 ± 0.011 strokes/second). Effective drug loading was attained for both pyrazinamide (97.230 ± 2.570%w/w) and rifampicin (97.610 ± 0.020%w/w) and drug release followed a zero-order kinetic model (R(2) = 0.990) for both drugs. Microscopic examinations confirmed drug encapsulation efficiency and showed that the particulates were micro-dimensional in nature (n < 700.000 µm). The formulation was physicochemically stable with no chemically irreversible drug-excipient interactions based on the results of characterization experiments performed. Findings from organoleptic evaluations generated an overall rating of 4.000 ± 0.000 for its attractive appearance and colour 5.000 ± 0.000 confirming its excellent taste and extremely pleasant smell. Preliminary cytotoxicity studies showed a cell viability above 70.000% which indicates that the FDC formulation was biocompatible. The optimized formulation was environmentally stable either as a dry powder or reconstituted suspension. Accordingly, a stable and palatable FDC antimycobacterial reconstitutable oral suspension powder, intended for flexible dosing in children and adolescents, was optimally fabricated.
format Online
Article
Text
id pubmed-9861895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98618952023-01-22 A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation Rampedi, Penelope N. Ogunrombi, Modupe O. Wesley-Smith, James Adeleke, Oluwatoyin A. Pharmaceutics Article The scarcity of age-appropriate pharmaceutical formulations is one of the major challenges impeding successful management of tuberculosis (TB) prevalence in minors. To this end, we designed and assessed the quality of a multiparticulate reconstitutable suspension powder containing fixed dose rifampicin and pyrazinamide (150 mg/300 mg per 5 mL) which was prepared employing solid–liquid direct dispersion coupled with timed dehydration, and mechanical pulverization. The optimized formulation had a high production yield (96.000 ± 3.270%), displayed noteworthy powder flow quality (9.670 ± 1.150°), upon reconstitution the suspension flow property was non-Newtonian and was easily redispersible with gentle manual agitation (1.720 ± 0.011 strokes/second). Effective drug loading was attained for both pyrazinamide (97.230 ± 2.570%w/w) and rifampicin (97.610 ± 0.020%w/w) and drug release followed a zero-order kinetic model (R(2) = 0.990) for both drugs. Microscopic examinations confirmed drug encapsulation efficiency and showed that the particulates were micro-dimensional in nature (n < 700.000 µm). The formulation was physicochemically stable with no chemically irreversible drug-excipient interactions based on the results of characterization experiments performed. Findings from organoleptic evaluations generated an overall rating of 4.000 ± 0.000 for its attractive appearance and colour 5.000 ± 0.000 confirming its excellent taste and extremely pleasant smell. Preliminary cytotoxicity studies showed a cell viability above 70.000% which indicates that the FDC formulation was biocompatible. The optimized formulation was environmentally stable either as a dry powder or reconstituted suspension. Accordingly, a stable and palatable FDC antimycobacterial reconstitutable oral suspension powder, intended for flexible dosing in children and adolescents, was optimally fabricated. MDPI 2022-12-25 /pmc/articles/PMC9861895/ /pubmed/36678693 http://dx.doi.org/10.3390/pharmaceutics15010064 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rampedi, Penelope N.
Ogunrombi, Modupe O.
Wesley-Smith, James
Adeleke, Oluwatoyin A.
A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
title A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
title_full A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
title_fullStr A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
title_full_unstemmed A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
title_short A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation
title_sort micro-configured multiparticulate reconstitutable suspension powder of fixed dose rifampicin and pyrazinamide: optimal fabrication and in vitro quality evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861895/
https://www.ncbi.nlm.nih.gov/pubmed/36678693
http://dx.doi.org/10.3390/pharmaceutics15010064
work_keys_str_mv AT rampedipenelopen amicroconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT ogunrombimodupeo amicroconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT wesleysmithjames amicroconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT adelekeoluwatoyina amicroconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT rampedipenelopen microconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT ogunrombimodupeo microconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT wesleysmithjames microconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation
AT adelekeoluwatoyina microconfiguredmultiparticulatereconstitutablesuspensionpowderoffixeddoserifampicinandpyrazinamideoptimalfabricationandinvitroqualityevaluation